biomedicina slovenica


"FASTING" : 120

  1. Chiofalo Benito; Laganà Antonio Simone; Palmara Vittorio Italo; Granese Roberta; Corrado Giacomo; Mancini Emanuela; Vitale Salvatore Giovanni; Ban Helena; Vrtačnik-Bokal Eda; Triolo Onofrio
    Fasting as possible complementary approach for polycystic ovary syndrome
    2017
  2. Štiglic Gregor; Fijačko Nino; Stožer Andraž; Sheikh Aziz; Pajnkihar Majda
    Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population
    2016
  3. Pyörälä Kalevi; Keber Irena; Škof Erik; Špan Matjaž; Salapura Vladka; Marn K.; Turk Josip
    Risk factor management in diabetic and non-diabetic patients with coronary heart disease
    2004
  4. Scherbakov Nadja; Bauer Maximiliane; Sandek Anja; Szabo Tibor; Töpper Agnieszka; Jankowska Eva A.; Springer Jochen; Von Haehling Stephan; Anker Stefan D.; Lainščak Mitja; Engeli Stefan; Düngen Hans-Dirk; Doehner Wolfram
    Insulin resistance in heart failure
    2015
  5. Perdan-Pirkmajer Katja; Pirkmajer Sergej; Praprotnik Sonja; Hočevar Alojzija; Rotar Žiga; Gašperšič Nataša; Sodin-Šemrl Snežna; Žibert Janez; Omersel Jasna; Tomšič Matija; Ambrožič Aleš
    Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis
    2016
  6. Čokolič Miro; Hren Rok
    Alendronate is safe and effective during long-term therapy in patients with osteoporosis and impaired fasting glucose
    2004
  7. Čokolič Miro; Hren Rok
    A five-year alendronate treatment of postmenopausal osteoporosis in patients with impaired fasting glucose
    2004
  8. Kmet Marko; Rajer Borut; Pernat Andrej
    Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose
    2014
  9. Locatelli Igor; Rostohar Vesna; Voinovich Dario; Bogataj Marija; Mrhar Aleš
    Evaluation of disolution profiles by the aid of a model of gastric emptying of tablets under fasting conditions
    2008
  10. Pavičić Baldani Dinka; Skrgatić Lana; Černe Jasmina Živa; Kralik Oguic Sasa; Geršak Blaž M.; Geršak Ksenija
    Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome
    2014
  11. Avberšek-Lužnik Ivica; Gartner Maja
    Laboratorijske preiskave - orodje za spremljanje hiperlipidemije in sladkorne bolezni
    2014
  12. Bavec Aljoša
    (Poly)peptide-based therapy for diabetes mellitus
    2014
  13. Klen Jasna; Goričar Katja; Janež Andrej; Dolžan Vita
    The role of genetic factors and kidney and liver function in glycemic control in type 2 diabetes patients on long-term metformin and sulphonylurea cotreatment
    2014
  14. Klen Jasna; Dolžan Vita; Janež Andrej
    CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
    2014
  15. Ferk Polonca; Geršak Ksenija
    Association of -108 C>T PON1 polymorphism with polycystic ovary syndrome
    2014
  16. Pham M N; Kolb Helga; Battelino Tadej; Ludvigsson Johnny; Pozzilli Paolo; Zivehe F.; Roden M.; Mandrup-Poulsen Thomas; Schloot Nanette C.
    Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes
    2013
  17. Pavičić Baldani Dinka; Skrgatić Lana; Černe Jasmina Živa; Ferk Polonca; Šimunić Velimir; Geršak Ksenija
    Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome
    2014
  18. Stegnar Mojca; Knežević Anja; Božič Mojca
    The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthysubjects
    2010
  19. Žen Jurančič Marijana; Erjavec Tatjana; Majdič Neža; Šavrin Rajmond
    Dejavniki tveganja za srčno-žilne bolezni pri bolnikih z okvaro hrbtenjače po končani primarni rehabilitaciji
    [Risk factors for cardiovascular diseases in patients with spinal cord injury after discharge from primary rehabilitation]
    2013
  20. Šantl-Letonja Marija; Letonja Mitja; Nikolajević-Starčević Jovana; Petrovič Danijel
    Ultrasonographic and classical risk factors of carotid atherosclerosis in patients with type-2 diabetes mellitus
    [Ultrazvočni in klasični dejavniki tveganja karotidne ateroskleroze pri bolnikih s sladkorno boleznijo tipa 2]
    2013
  21. Skrgatić Lana; Pavičić Baldani Dinka; Geršak Ksenija; Černe Jasmina Živa; Ferk Polonca; Čorić Mario
    Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycistic ovary syndrome in Croatian women
    [Polimorfizmi gena za INS, INSR i IRS-1 nisu povezani sa sindromom policističnih jajnika u hrvatskoj populaciji PCOS bolesnica]
    2013
  22. Ludvigsson Johnny; Krisky David; Casas Rosaura; Battelino Tadej; Castano Luis; Greening James; Kordonouri Olga; Otonkoski Timo; Pozzilli Paolo; Robert Jean-Jacques; Veeze Henk J; Palmer Jerry
    GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
    2012
  23. Buzzetti Raffaella; Cernea Simona; Petrone Antonio; Capizzi Marco; Spoletini Marlaluisa; Zampetti Simona; Guglielmi Chiara; Venditti Chiara; Pozzilli Paolo; Battelino Tadej
    C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study
    2011
  24. Nikolajević-Starčević Jovana; Globočnik-Petrovič Mojca; Petrovič Danijel
    A1/A2 polymorphism of the glycoprotein IIIa gene and diabetic retinopathy in Caucasians with type 2 diabetes
    2011
  25. Buse JB; Rosenstock J; Sesti G; Janež A
    Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
    2009
  26. Skrgatic L; Pavicic-Baldani D; Černe JZ; Ferk P; Geršak K
    CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels
    2012
  27. Polašek Ozren; Kolčić Ivana; Smoljanović Ankica; Stojanović Dražen; Grgićš Matijana; Ebling Barbara; Klarić Maja; Milas Josip; Puntarić Dinko
    Demonstrating reduced environmental and genetic diversity in human isolates by analysis of blood lipid levels
    2006
  28. Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
    Lipin 1 gene polymorphisms in polycystic ovary syndrome
    2011
  29. Sinkovič Andreja; Šuran David; Lokar Lidija; Fliser Eva; Škerget Mojca; Novak Zoran; Knez Željko
    Rosemary extracts improve flow-mediated dilatation of the brachial artery and plasma PAI-1 activity in healthy young volunteers
    2011
  30. Crnčević-Orlić Željka; Ružić Alen; Miletić Bojan; Petrović Oleg; Zaputović Luka; Kehler Tatjana; Rački Sanjin; Kapović Miljenko
    Predictive parameters of gestational diabetes mellitus
    2007
  31. Tacer KF; Pompon D; Rozman D
    Adaptation of cholesterol synthesis to fasting and TNF-alpha: Profiling cholesterol intermediates in the liver, brain, and testis
    2010
  32. Zaletel J; Pongrac-Barlovič D; Preželj J
    Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with type 2 diabetes
    2010
  33. Rocic B; Bedernjak-Bajuk N; Rocic P; Weber DS; Boras J; Lovrencic MV
    Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
    2009
  34. Szabo Tibor; von Haehling Stephan; Habedank Dirk; Rauchhaus Mathias; Lainščak Mitja; Sandek Anja; Schefold Joerg; Anker Stefan D; Doehner Wolfram
    Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure
    2009
  35. Fon-Tacer Klementina
    Hormon stradanja fibroblastni rastni dejavnik 21 - novo zdravilo za debelost in metabolni sindrom?
    [Fasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?]
    2009
  36. Merc Matjaž; Notar Luka; Janež Andrej
    Insulinska rezistenca pri bolnicah s sindromom policističnih ovarijev
    [Insulin resistance in patients with polycystic ovary syndrome]
    2009
  37. Janša Karmen
    Povečana debelina intime-medije karotidnih arterij in dejavniki srčno-žilne ogroženosti žensk, ki so imele nosečnostno sladkorno bolezen
    [Increased intima-media thickness of carotid arteries and cardiovascular risk factors in women with previous gestational diabetes mellitus]
    2009
  38. Fon-Tacer Klementina
    Citokromi P450, jedrni receptorji in fibroblastni rastni dejavniki - nove endokribne osi kot potencialna prijemališča za zdravljenje presnovnih bolezni
    [Cytochromes P450, nuclear receptors, and fibroblast growth factors - new endocrine axes as potential drug targets to treat metabolic disorders]
    2009
  39. Greenbaum Carla J; Mandrup-Poulsen Thomas; McGee Paula F; Battelino Tadej; Haastert Burkhard; Ludvigsson Johnny; Pozzilli Paolo; Lachin John M; Kolb Hubert
    Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes
    2008
  40. Ferk P; Perme MP; Geršak K
    Insulin gene polymorphism in women with polycystic ovary syndrome
    2008
  41. Žižek Bogomir; Poredoš Pavel; Trojar Andrej; Željko Tadej
    Diastolic dysfunction is associated with insulin resistance, but not with aldosterone level in normotensive offspring of hypertensive families
    2008
  42. Silič Anja; Janež Andrej; Tomažič Janez; Karner Primož; Vidmar Ludvik; Sharma Prem; Matičič Mojca
    Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial
    2007
  43. Vrtovec Bojan; Zemljič Gregor; Bunc Matjaž
    Telmisartan therapy is associated with improved fasting glucose levels in non-diabetic patients with chronic heart failure
    2008
  44. Jensterle Mojca; Weber Matthias; Pfeifer Marija; Preželj Janez; Pfutzner Andreas; Janež Andrej
    Assessment of insulin resistance in young women with polycystic ovary syndrome
    2008
  45. Vrtovec Bojan; Zemljič Gregor; Bunc Matjaž
    Telmisartan therapy is associated with improved fasting glucose levels in non-diabetic patients with chronic heart failure
    2008
  46. Davies M; Lavalle-Gonzalez F; Storms F; Gomis R; Battelino T; Koselj M; Ravnik-Oblak M; Šubic J; Tomažič M; Urbančič V; Vrtovec M
    Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial
    2008
  47. Čokolič Miro; Hren Rok
    Remaining effects of a five-year alendronate treatment in patients with post-menopausal osteoporosis and impaired fasting glucose
    2006
  48. Simončič Matjaž; Režen Tadeja; Juvan Peter; Fievet Catherine; Staels Bart; Rozman Damjana; Horvat Simon
    Transcriptome analysis revealed association of some P450 genes with obesity in a polygenic obese mouse model
    2008
  49. Režen Tadeja; Juvan Peter; Fon-Tacer Klementina; Kuzman Drago; Roth Adrian; Pompon Denis; Aggerbeck L.P.; Meyer Urs; Rozman Damjana
    The sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism
    2008
  50. Jensterle Mojca; Janež Andrej; Vrtovec Bojan; Meden-Vrtovec Helena; Pfeifer Marija; Preželj Janez; Kocjan Tomaž
    Decreased androgen levels and improved menstrual pattern after angiotension II receptor antagonist Telmisartan treatment in four hypertensive patients with polycistic ovary syndrome: case series
    2007
  51. Štupar Janez; Vrtovec Matjaž; Dolinšek Franci
    Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus
    2007
  52. Kovačič D; Marinšek M; Gobec L; Lainščak M; Podbregar M
    Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure
    2008
  53. Fon-Tacer Klementina; Kuzman Drago; Seliškar Matej; Pompon Denis; Rozman Damjana
    TNF-{alpha} interferes with lipid homeostasis and activates acute and pro-atherogenic processes
    2007
  54. Čokolič Miro; Hren Rok
    Treatment of postmenopausal osteoporosis with alendronate and calcium in patients with impaired fasting glucose
    2000
  55. Ferk Polona
    Nekateri genetski dejavniki pri bolnicah s sindromom policističnih jajčnikov
    2006
  56. Cokolič M; Hren R
    Effect of two-year discontinuation after five years of alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    2006
  57. Cokolič Miro; Hren Rok
    Effect of two-year discontinuation after five years alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    2006
  58. Meden-Vrtovec Helena
    Prijevremena menopauza
    [Premature menopause]
    2005
  59. Šimenko Jože; Frangež Mira; Simonič Alenka
    Urgentna intubacija
    [Rapid sequence intubation]
    2005
  60. Tomažič J; Karner P; Vidmar L; Matičič M; Sharma PM; Janež A
    Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART
    2005
  61. Car Josip
    Fasting and asthma: an opportunity for building patient-doctor partnership
    2004
  62. Gorišek-Miksić Nina
    Vpliv različnih dejavnikov na nastanek metabolnega sindroma z lipodistrofijo pri slovenskih bolnikih, okuženih s HIV
    2005
  63. Fon-Tacer Klementina
    Tkivno-specifično uravnavanje biosinteze holesterola v modih, jetrih in možganih v različnih fizioloških/patofizioloških pogojih
    [Tissue specific regulation of cholesterol biosynthesis in the testes, liver and brain in different physiological/pathophysiological conditions]
    2005
  64. Janež Andrej
    Mesto tiazolidindionov v zdravljenju sladkorne bolezni tipa 2
    [The role of thiazolidinediones in the treatment of type 2 diabetes mellitus]
    2004
  65. Šebeštjen Miran; Keber Irena; Žegura Branka; Simčič Saša; Božič Mojca; Migaud-Fressart Martine; Stegnar Mojca
    Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors
    2004
  66. Kupnik Dejan; Golub Mirjam
    Hitra sekvenčna intubacija v predbolnišničnem okolju - prikaz primerov bolnikov
    [Rapid sequence intubation in the prehospital setting - case reports]
    2004
  67. Šabovič Mišo; Lavre Simona; Keber Irena
    Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome
    2004
  68. Čokolič M; Hren R
    A five-year alendronate treatment of postmenopausal osteoporosis in patients with impaired fasting glucose
    2004
  69. Zaletel Jelka
    Metabolni sindrom
    [The metabolic syndrome]
    2003
  70. Ravnik-Oblak Maja; Mrevlje Franc
    Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure
    1995
  71. Cokolič M; Hren R
    Impaired fasting glucose and treatment of postmenopausal osteoporosis with alendronate
    2003
  72. Bizjak-Mali Lilijana
    Vpliv stradanja na ultrastrukturo hepatocitov močerila (Proteus anguinus, Amphibia, Urodela)
    [Influence of the starvation on the ultrastructure of the hepatocytes in Proteus anguinus (Amphibia, Urodela)]
    2003
  73. Žegura Branka; Keber Irena; Šebeštjen Miran; Koenig Wolfgang
    Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis
    2003
  74. Tomažič J
    Standard of care for HIV infected individuals/aids patients in Slovenia: short review
    2003
  75. Zaletel Jelka; Janež Andrej; Kocijančič Andreja
    Program hujšanja za bolnike s sladkorno boleznijo tipa 2 ob zdravljenju z orlistatom - naše izkušnje
    [Weight management program for patients with diabetes mellitus type 2 treated with orlistat - our experiences]
    2003
  76. Mlakar Boštjan
    Pogosta vprašanja ali Našim mamam
    2002
  77. Škof Erik; Špan Matjaž; Keber Irena
    Secondary prevention in patients several years after myocardial infarction: comparison of an outpatient and an inpatient rehabilitation programme
    2001
  78. Čokolič Miro; Hren R
    Alendronate treatment of patients with postmenopausal osteoporosis and impaired fasting glucose
    2001
  79. Žemva Aleš
    Homocysteine - a new marker of cardiovascular risk
    2001
  80. Bombek Mirko
    Smo naredili za preprečevanje bolezni srca in ožilja dovolj? Razširjenost dejavnikov ogrožanja za bolezni srca in ožilja med prebivalci Maribora in okolice
    [Are we doing enough for prevention of cardiopvascular diseases? Distribution of coronary risk factors in population of Maribor region]
    2001
  81. Strmole Darinka
    Prehranjevalne navade in zdravstveno stanje sedmošolcev s povišanim indeksom telesne mase
    [Nutritional habits and healt status of 12-14 years old schoolchildren with increased BMI]
    2001
  82. Žemva Aleš; Žemva Žarka
    Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity
    2000
  83. Šebeštjen Miran; Žegura Branka; Gužič-Salobir Barbara; Keber Irena
    Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia
    2001
  84. Možina Hugon
    Prehrana bolnika s kronično obstruktivno pljučno boleznijo (KOPB), ledvičnim ali jetrnim obolenjem
    2000
  85. Žegura Branka
    Funkcijske lastnosti arterijske žilne stene, hemostaza in krvni lipidi po peroralnem ali transdermalnem nadomeščanju estrogenov po kirurški menopavzi
    2000
  86. Božič Mojca; Stegnar Mojca; Fermo Isabella; Ritonja Anka; Peternel Polona; Stare Janez; D'Angelo Armando
    Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
    2000
  87. Tršan Vida; Šoln Darinka
    Preventiva zvišanega krvnega sladkorja
    [Prevention of elevated blood sugar]
    1997
  88. Medvešček Marko
    Prandialna regulacija glikemije: nov način zdravljenja sladkorne bolezni tipa 2
    [Prandial glucose regulation: new approach to the treatment of type 2 diabetes]
    1999
  89. Žemva A; Marn-Pernat A; Jelenc M; Žemva Ž
    Is diastolic dysfunction related to insulin resistance?
    1998
  90. Žemva Aleš; Marn-Pernat Andreja; Jelenc Marjetka; Žemva Žarka
    Diastolic function and insulin resistance in essential hypertension
    1998
  91. Jelenc Marjetka; Žemva Aleš; Marn-Pernat Andreja; Žemva Žarka
    Are insulin metabolism and night-time blood pressure related to left venticular hypertrophy?
    1998
  92. Keber Irena; Škof Erik; Špan Matjaž; Štlek Mateja; Gužič Barbara
    Učinkovitost pri izvajanju sekundarne preventive po srčnem infarktu: razlike med tremi slovenskimi mesti
    [Efficacy in application of secondary preventive measures after myocardinal infarction: the differences between three Slovenian cities]
    1998
  93. Stegnar Mojca; Uhrin Pavel; Peternel Polona; Mavri Alenka; Salobir-Pajnič Barbara; Stare Janez; Binder Bernd R
    The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism
    1998
  94. Lavrenčič Aleša; Kosmina Barbara; Keber Irena; Videčnik Viktor; Keber Dušan
    Carotid intima-media thickness in young patients with familial hypercholesterolaemia
    1996
  95. Stegnar M; Peternel P; Uhrin P; Cvelbar-Marinko T; Goršič-Tomažič K; Binder BR
    Fibrinolysis in patients with the 1691 G-A mutation in factor V gene and history of deep vein thrombosis
    1997
  96. Stegnar Mojca; Božič Mojca
    Pomen homocisteina pri razvoju žilnih bolezni
    [The role of homocysteine in the development of vascular disease]
    1998
  97. Kuhar Boris
    Post
    1997
  98. Koselj Miha
    Sladkorna bolezen v starosti
    [Diabetes mellitus in elderly]
    1997
  99. Meden-Vrtovec H; Tomaževič T; Osredkar J; Verdenik I
    Ability of oocytes to fertilize with regard to insulin-like growth factor I (IGF-I) and IGF-binding proteins (IGFBP-1 and -3) levels in unstimulated IVF-ET cycles
    1997
  100. Meh D; Denišlič M
    Nerve fiber dysfunction in type 1 diabetic children: relation to age, duration of the disease and metabolic control
    1996

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics